Home » Topics » Disease categories and therapies » Immune

Immune
RSS

GenVec receives SBIR grant of USD 600,000 for respiratory syncytial virus vaccine

May 9, 2008

Astellas receives FDA approvable letter for FK-506 modified release formulation

May 8, 2008

Novel agents for treating autoimmune diseases disclosed in recent Pharmacopeia patents

May 7, 2008

Emergent BioSolutions acquires rPA-102 anthrax vaccine from VaxGen for USD 2 million

May 6, 2008

Recent Synta patent reports novel immunosuppressant agents

May 5, 2008

3M and Infectious Disease Research Institute collaborate on vaccine adjuvants

May 5, 2008

ImmuneRegen to supply adjuvant to DynPort for Venezuelan equine encephalitis vaccine

May 5, 2008

KaloBios completes dosing in U.S. phase I clinical trial of monoclonal antibody KB-003

April 30, 2008

Avesthagen and ShigaMedix enter agreement for vaccines against HPV and TB

April 30, 2008

Cytheris initiates phase I clinical trial of CYT-107 in immunodeficient transplant recipients

April 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...